Surya Pharmaceutical Ltd.
NSE: SURYAPHARM | BSE: 532516
₹0.16
₹-0.01
(-5.88%)
As on 14-Sep-2015IST
Market cap
₹3 Cr
Revenue (TTM)
₹3 Cr
P/E Ratio
0
P/B Ratio
-0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-333 Cr
-
ROE
-451.8 %
-
ROCE
-12.7 %
-
Industry P/E
40.16
-
EV/EBITDA
-40.9
-
Debt to Equity
-37
-
Book Value
₹--
-
EPS
₹12.8
-
Face value
1
-
Shares outstanding
202,752,380
10 Years Aggregate
CFO
₹833.42 Cr
EBITDA
₹374.53 Cr
Net Profit
₹-312.98 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Surya Pharmaceutical
| -23.8 | -20.0 | -11.1 | -87.6 | -53.0 | -64.5 | -36.7 |
|
BSE Sensex*
| -8.7 | 1.6 | 1.7 | -4.3 | 6.0 | 6.7 | 10.8 |
|
BSE Healthcare#
| 18.0 | 3.8 | 8.0 | 16.3 | 22.9 | 14.9 | 12.3 |
|
Company
|
2014
|
|---|---|
|
Surya Pharmaceutical
| -83.7 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Surya Pharmaceutical
|
0.2 | 3.2 | 2.6 | 258.7 | -2,984.6 | -- | 0 | 0.0 |
| 3,320.4 | 27,186.1 | 1,461.8 | 387.4 | 34.5 | 25.2 | 70.4 | 15.7 | |
| 831.9 | 16,236.1 | 7,784.0 | 688.5 | 10.6 | 14 | 23.4 | 2.8 | |
| 459.4 | 17,459.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 164.4 | 4.5 | |
| 846.4 | 20,475.5 | 5,632.3 | 662.4 | 17.2 | 14.3 | 30.9 | 4.2 | |
| 1,517.4 | 17,217.6 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 2.9 | |
| 213.4 | 28,284.5 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,847.8 | 29,986.1 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104 | 22.3 | |
| 415.5 | 16,681.6 | 3,600.2 | 221.0 | 9.7 | 5.6 | 75.5 | 3.5 | |
| 1,942.9 | 30,609.5 | 3,564.0 | 414.0 | 15.3 | 8.4 | 74.8 | 6.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Surya Pharmaceutical
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1992
-
Chairman
Rajiv Goyal
-
Managing Director
Rajiv Goyal
-
Headquarters
New Delhi, New Delhi
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Surya Pharmaceutical
What is the current share price of Surya Pharmaceutical Ltd Today?
The share price of Surya Pharmaceutical Ltd is ₹0.16 (BSE) and ₹1.30 (NSE) as of 14-Sep-2015 IST. Surya Pharmaceutical Ltd has given a return of -52.99% in the last 3 years.
What is the current PB & PE ratio of Surya Pharmaceutical Ltd?
The P/E ratio of Surya Pharmaceutical Ltd is 0.01 times as on 14-Sep-2015, a 100 discount to its peers’ median range of 40.16 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2013 |
0.00 |
-0.35 |
2012 |
0.00 |
1.18 |
2011 |
5.80 |
1.06 |
2010 |
0.38 |
0.93 |
2009 |
0.14 |
0.34 |
What is the 52 Week High and Low of Surya Pharmaceutical Ltd?
The 52-week high and low of Surya Pharmaceutical Ltd are Rs -- and Rs -- as of 27-Aug-2026.
What is the market cap of Surya Pharmaceutical Ltd?
Surya Pharmaceutical Ltd has a market capitalisation of ₹ 3 Cr as on 14-Sep-2015. As per SEBI classification, it is a company.
Should I invest in Surya Pharmaceutical Ltd?
Before investing in Surya Pharmaceutical Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.